These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 34737725)

  • 41. Targeting the Intestinal Microbiota to Prevent Type 2 Diabetes and Enhance the Effect of Metformin on Glycaemia: A Randomised Controlled Pilot Study.
    Palacios T; Vitetta L; Coulson S; Madigan CD; Lam YY; Manuel R; Briskey D; Hendy C; Kim JN; Ishoey T; Soto-Giron MJ; Schott EM; Toledo G; Caterson ID
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32660025
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cultivable butyrate-producing bacteria of elderly Japanese diagnosed with Alzheimer's disease.
    Nguyen TTT; Fujimura Y; Mimura I; Fujii Y; Nguyen NL; Arakawa K; Morita H
    J Microbiol; 2018 Oct; 56(10):760-771. PubMed ID: 30136260
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral histidine affects gut microbiota and MAIT cells improving glycemic control in type 2 diabetes patients.
    Warmbrunn MV; Attaye I; Aron-Wisnewsky J; Rampanelli E; van der Vossen EWJ; Hao Y; Koopen A; Bergh PO; Stols-Gonçalves D; Mohamed N; Kemper M; Verdoes X; Wortelboer K; Davids M; Belda E; André S; Hazen S; Clement K; Groen B; van Raalte DH; Herrema H; Backhed F; Nieuwdorp M
    Gut Microbes; 2024; 16(1):2370616. PubMed ID: 38961712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
    Forslund K; Hildebrand F; Nielsen T; Falony G; Le Chatelier E; Sunagawa S; Prifti E; Vieira-Silva S; Gudmundsdottir V; Pedersen HK; Arumugam M; Kristiansen K; Voigt AY; Vestergaard H; Hercog R; Costea PI; Kultima JR; Li J; Jørgensen T; Levenez F; Dore J; ; Nielsen HB; Brunak S; Raes J; Hansen T; Wang J; Ehrlich SD; Bork P; Pedersen O
    Nature; 2015 Dec; 528(7581):262-266. PubMed ID: 26633628
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Butyrate as a potential therapeutic agent for neurodegenerative disorders.
    Chakraborty P; Gamage HKAH; Laird AS
    Neurochem Int; 2024 Jun; 176():105745. PubMed ID: 38641025
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation.
    Kasubuchi M; Hasegawa S; Hiramatsu T; Ichimura A; Kimura I
    Nutrients; 2015 Apr; 7(4):2839-49. PubMed ID: 25875123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of butyrate, a histone deacetylase inhibitor in diabetes mellitus: experimental evidence for therapeutic intervention.
    Khan S; Jena G
    Epigenomics; 2015; 7(4):669-80. PubMed ID: 26111036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects.
    Bouter K; Bakker GJ; Levin E; Hartstra AV; Kootte RS; Udayappan SD; Katiraei S; Bahler L; Gilijamse PW; Tremaroli V; Stahlman M; Holleman F; van Riel NAW; Verberne HJ; Romijn JA; Dallinga-Thie GM; Serlie MJ; Ackermans MT; Kemper EM; Willems van Dijk K; Backhed F; Groen AK; Nieuwdorp M
    Clin Transl Gastroenterol; 2018 May; 9(5):155. PubMed ID: 29799027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The metabolite butyrate produced by gut microbiota inhibits cachexia-associated skeletal muscle atrophy by regulating intestinal barrier function and macrophage polarization.
    Liu H; Xi Q; Tan S; Qu Y; Meng Q; Zhang Y; Cheng Y; Wu G
    Int Immunopharmacol; 2023 Nov; 124(Pt B):111001. PubMed ID: 37804658
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic Responses to Butyrate Supplementation in LF- and HF-Fed Mice Are Cohort-Dependent and Associated with Changes in Composition and Function of the Gut Microbiota.
    Lee S; Knotts TA; Goodson ML; Barboza M; Wudeck E; England G; Raybould HE
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33207675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gut microbiota-derived short-chain fatty acids protect against the progression of endometriosis.
    Chadchan SB; Popli P; Ambati CR; Tycksen E; Han SJ; Bulun SE; Putluri N; Biest SW; Kommagani R
    Life Sci Alliance; 2021 Dec; 4(12):. PubMed ID: 34593556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Melatonin alleviates titanium nanoparticles induced osteolysis via activation of butyrate/GPR109A signaling pathway.
    Wu Y; He F; Zhang C; Zhang Q; Su X; Zhu X; Liu A; Shi W; Lin W; Jin Z; Yang H; Lin J
    J Nanobiotechnology; 2021 Jun; 19(1):170. PubMed ID: 34092246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of banana powder (Musa acuminata Colla) on the composition of human fecal microbiota and metabolic output using in vitro fermentation.
    Tian DD; Xu XQ; Peng Q; Zhang YW; Zhang PB; Qiao Y; Shi B
    J Food Sci; 2020 Aug; 85(8):2554-2564. PubMed ID: 32677055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genome-scale community modelling elucidates the metabolic interaction in Indian type-2 diabetic gut microbiota.
    Beura S; Kundu P; Das AK; Ghosh A
    Sci Rep; 2024 Jul; 14(1):17259. PubMed ID: 39060274
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Consumption of partially hydrolysed guar gum stimulates Bifidobacteria and butyrate-producing bacteria in the human large intestine.
    Ohashi Y; Sumitani K; Tokunaga M; Ishihara N; Okubo T; Fujisawa T
    Benef Microbes; 2015; 6(4):451-5. PubMed ID: 25519526
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered gut microbiota and short chain fatty acids in Chinese children with autism spectrum disorder.
    Liu S; Li E; Sun Z; Fu D; Duan G; Jiang M; Yu Y; Mei L; Yang P; Tang Y; Zheng P
    Sci Rep; 2019 Jan; 9(1):287. PubMed ID: 30670726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis?
    Stilling RM; van de Wouw M; Clarke G; Stanton C; Dinan TG; Cryan JF
    Neurochem Int; 2016 Oct; 99():110-132. PubMed ID: 27346602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Positive Interventional Effect of Engineered Butyrate-Producing Bacteria on Metabolic Disorders and Intestinal Flora Disruption in Obese Mice.
    Wang L; Cheng X; Bai L; Gao M; Kang G; Cao X; Huang H
    Microbiol Spectr; 2022 Apr; 10(2):e0114721. PubMed ID: 35293806
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The mechanisms in the gut microbiota regulation and type 2 diabetes therapeutic activity of resistant starches.
    Li X; Chen R; Wen J; Ji R; Chen X; Cao Y; Yu Y; Zhao C
    Int J Biol Macromol; 2024 Aug; 274(Pt 1):133279. PubMed ID: 38906356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prebiotic potential of L-sorbose and xylitol in promoting the growth and metabolic activity of specific butyrate-producing bacteria in human fecal culture.
    Sato T; Kusuhara S; Yokoi W; Ito M; Miyazaki K
    FEMS Microbiol Ecol; 2017 Jan; 93(1):. PubMed ID: 27810878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.